South Korea
· Delayed Price · Currency is KRW BCWORLD PHARM. Statistics
Total Valuation
BCWORLD PHARM. has a market cap or net worth of KRW 43.12 billion. The enterprise value is 124.41 billion.
| Market Cap | 43.12B |
| Enterprise Value | 124.41B |
Important Dates
The next estimated earnings date is Tuesday, November 12, 2024.
| Earnings Date | Nov 12, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
BCWORLD PHARM. has 8.44 million shares outstanding. The number of shares has decreased by -0.42% in one year.
| Shares Outstanding | 8.44M |
| Shares Change (YoY) | -0.42% |
| Shares Change (QoQ) | +0.18% |
| Owned by Insiders (%) | 40.71% |
| Owned by Institutions (%) | n/a |
| Float | 4.99M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.59 |
| PB Ratio | 0.56 |
| P/FCF Ratio | 9.41 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 14.66, with an EV/FCF ratio of 27.15.
| EV / Earnings | -18.04 |
| EV / Sales | 1.71 |
| EV / EBITDA | 14.66 |
| EV / EBIT | 141.33 |
| EV / FCF | 27.15 |
Financial Position
The company has a current ratio of 0.52, with a Debt / Equity ratio of 117.90.
| Current Ratio | 0.52 |
| Quick Ratio | 0.29 |
| Debt / Equity | 117.90 |
| Debt / EBITDA | 10.55 |
| Debt / FCF | 19.54 |
| Interest Coverage | 0.17 |
Financial Efficiency
Return on equity (ROE) is -8.15% and return on invested capital (ROIC) is 0.32%.
| Return on Equity (ROE) | -8.15% |
| Return on Assets (ROA) | 0.30% |
| Return on Capital (ROIC) | 0.32% |
| Revenue Per Employee | 256.90M |
| Profits Per Employee | -24.28M |
| Employee Count | 284 |
| Asset Turnover | 0.40 |
| Inventory Turnover | 2.54 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -23.47% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | -23.47% |
| 50-Day Moving Average | 5,578.40 |
| 200-Day Moving Average | 6,148.40 |
| Relative Strength Index (RSI) | 37.91 |
| Average Volume (20 Days) | 7,986 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, BCWORLD PHARM. had revenue of KRW 72.96 billion and -6.90 billion in losses. Loss per share was -817.30.
| Revenue | 72.96B |
| Gross Profit | 27.86B |
| Operating Income | 880.27M |
| Pretax Income | -3.58B |
| Net Income | -6.90B |
| EBITDA | 8.48B |
| EBIT | 880.27M |
| Loss Per Share | -817.30 |
Balance Sheet
The company has 6.60 billion in cash and 89.55 billion in debt, giving a net cash position of -82.95 billion or -9,829.89 per share.
| Cash & Cash Equivalents | 6.60B |
| Total Debt | 89.55B |
| Net Cash | -82.95B |
| Net Cash Per Share | -9,829.89 |
| Equity (Book Value) | 75.95B |
| Book Value Per Share | 9,197.08 |
| Working Capital | -41.49B |
Cash Flow
In the last 12 months, operating cash flow was 7.29 billion and capital expenditures -2.71 billion, giving a free cash flow of 4.58 billion.
| Operating Cash Flow | 7.29B |
| Capital Expenditures | -2.71B |
| Free Cash Flow | 4.58B |
| FCF Per Share | 542.95 |
Margins
Gross margin is 38.19%, with operating and profit margins of 1.21% and -9.45%.
| Gross Margin | 38.19% |
| Operating Margin | 1.21% |
| Pretax Margin | -4.91% |
| Profit Margin | -9.45% |
| EBITDA Margin | 11.63% |
| EBIT Margin | 1.21% |
| FCF Margin | 6.28% |
Dividends & Yields
This stock pays an annual dividend of 100.00, which amounts to a dividend yield of 1.96%.
| Dividend Per Share | 100.00 |
| Dividend Yield | 1.96% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 0.42% |
| Shareholder Yield | 2.39% |
| Earnings Yield | -15.99% |
| FCF Yield | 10.63% |
Stock Splits
The last stock split was on December 27, 2019. It was a forward split with a ratio of 1.1.
| Last Split Date | Dec 27, 2019 |
| Split Type | Forward |
| Split Ratio | 1.1 |